• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Epicyn gel wins derm indication

The Food and Drug Administration has approved Epicyn HydroGel (Oculus Innovative Sciences) for treatment of various dermatoses and burns, MedPage Today reports.

Washington - The Food and Drug Administration has approved Epicyn HydroGel (Oculus Innovative Sciences) for treatment of various dermatoses and burns, MedPage Today reports.

The agency approved the gel as a medical device. The gel is now indicated for treatment of burning, itching and pain associated with atopic and radiation dermatitis, as well as for pain resulting from first- and second-degree burns.

According to an Oculus statement, the gel also maintains “a moist wound and skin environment” to help treat dry and waxy skin.

Available only by prescription, Epicyn HydroGel is based on Oculus’ Microcyn oxychlorine compound and is a shelf-stable hypochlorous acid formulation.

Related Videos
E. James Song is featured in this video series.
E. James Song is featured in this video series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
E. James Song is featured in this video series.
© 2024 MJH Life Sciences

All rights reserved.